Rexam proposes sale of remaining healthcare business to Berry Plastics

Published: 25-Mar-2014
Packaging Finance

Sale of two other divisions announced at the beginning of February proceeding on schedule


Global beverage can maker Rexam has received a binding offer of US$135m in cash, subject to certain adjustments at closing, from Berry Plastics Group to acquire the remaining Containers & Closures division of Rexam’s Healthcare business.

The transaction requires consultation with French works council and is conditional on the necessary regulatory approvals. It is expected to complete around the middle of this year.

The announcement follows that of 3 February 2014 regarding the proposed sale of the other two divisions within Rexam’s Healthcare business. That transaction is progressing according to plan and is expected to complete in the second quarter of this year, following which Rexam plans to return around £450m to shareholders.

  • Companies:
  • Nemera
  • Berry Global
See more

You may also like

Packaging

Berry launches closed Politainer system for enhanced safety and dispensing

Read more
System enhances protection during emptying and requires less truckload shipments

Trending Articles

  1. Lonza Capsules & Health Ingredients expands capsule manufacturing capacity in India and China New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to the business and the APAC region
  2. Novo Holdings completes acquisition of Catalent Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark
  3. Newcells Biotech raises additional funding from investors Newcells Biotech, a leading drug discovery partner specialising in the development of in vitro models and bespoke assay services to improve the prediction of in vivo human outcomes, has raised a further £1.2m from existing investors Mercia Ventures, Northstar Ventures and North East Finance
  4. ACG expands global footprint with new capsule manufacturing facility in Thailand New capsule manufacturing facility in Rayong, Thailand, is strategically positioned to serve key Asian markets
  5. £20m Scottish oligonucleotide manufacturing innovation centre now under construction The centre will act as an innovation centre, assisting in the development and optimisation of oligonucleotide manufacturing processes, while also bolstering the UK's biopharmaceutical presence

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Packaging

Berry launches closed Politainer system for enhanced safety and dispensing

System enhances protection during emptying and requires less truckload shipments
Packaging

Berry to demonstrate its patient-centred approach at PCI Days 2024

As part of the company’s ‘Dose Better’ initiative, Berry will present a range of products that help deliver a better healthcare experience
Finance

Berry Global invests to increase production capacity for healthcare products

Berry Global Group has invested in additional assets and manufacturing capabilities to increase its healthcare production capacity by up to 30% across three of its European sites
Manufacturing

Nemera extends manufacturing capabilities in North America

With a newly acquired space in Vernon Hills, Nemera has opened a third location in the US, in addition to the manufacturing facility in Buffalo Grove and Innovation Center in Chicago
Finance

Nemera to build drug delivery device facility in Poland

The production plant is being built on an area of 5 hectares with dedicated expandable clean room space
Finance

Nemera to acquire Copernicus

The acquisition establishes Nemera’s operations footprint in Eastern Europe.
Packaging

Nemera's Advancia Snap-on nasal spray pump launches in South Korea

JW Pharmaceutical has released its decongestant range for adults and kids
Subscribe now